These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 17173239)
1. The kidney and hypertension: over 70 years of research. Campese VM; Park J J Nephrol; 2006; 19(6):691-8. PubMed ID: 17173239 [TBL] [Abstract][Full Text] [Related]
2. Renin, angiotensin, aldosterone and hormonal regulation of arterial pressure and salt balance. Introductory remarks. Laragh JH Fed Proc; 1967; 26(1):39-41. PubMed ID: 4289566 [No Abstract] [Full Text] [Related]
3. [Pathogenesis of renal hypertension]. Cottier P Schweiz Med Wochenschr; 1975 Dec; 105(50):1670-7. PubMed ID: 1215954 [TBL] [Abstract][Full Text] [Related]
4. Role of aldosterone and angiotensin II in insulin resistance: an update. Lastra-Lastra G; Sowers JR; Restrepo-Erazo K; Manrique-Acevedo C; Lastra-González G Clin Endocrinol (Oxf); 2009 Jul; 71(1):1-6. PubMed ID: 19138313 [TBL] [Abstract][Full Text] [Related]
5. The kidney and the neurogenic control of blood pressure in renal disease. Campese VM J Nephrol; 2000; 13(3):221-4. PubMed ID: 10928299 [TBL] [Abstract][Full Text] [Related]
6. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?]. Horký K Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167 [TBL] [Abstract][Full Text] [Related]
7. Fluid balance, renal function, and blood pressure. Guyton AC; Young DB; DeClue JW; Trippodo N; Hall JE Clin Nephrol; 1975 Oct; 4(4):122-6. PubMed ID: 1192615 [TBL] [Abstract][Full Text] [Related]
13. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension]. Abassi Z; Armaly Z; Nakhoul F; Hoffman A Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632 [TBL] [Abstract][Full Text] [Related]
14. Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys. Chandramohan G; Bai Y; Norris K; Rodriguez-Iturbe B; Vaziri ND Am J Nephrol; 2008; 28(1):158-67. PubMed ID: 17951998 [TBL] [Abstract][Full Text] [Related]
15. Kidney and hypertension-causes. Update 2003. Ritz E; Adamczak M; Zeier M Herz; 2003 Dec; 28(8):663-7. PubMed ID: 14689099 [TBL] [Abstract][Full Text] [Related]
16. Contribution of sympathetic neural reflexes to mineralocorticoid escape. Romero JC; Knox FG; Opgenorth TJ; Granger JP; Keiser JA Fed Proc; 1985 May; 44(8):2382-7. PubMed ID: 3886427 [TBL] [Abstract][Full Text] [Related]
17. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. Schrier RW J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226 [TBL] [Abstract][Full Text] [Related]
18. [The role of kidney in pathogenesis of arterial hypertension]. Wojtusik S; Sułowicz W Przegl Lek; 2012; 69(9):680-6. PubMed ID: 23401989 [TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease. Steele JL; Henik RA; Stepien RL Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747 [TBL] [Abstract][Full Text] [Related]
20. A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men. Adamzik M; Frey UH; Bitzer K; Jakob H; Baba HA; Schmieder RE; Schneider MP; Heusch G; Peters J; Siffert W Basic Res Cardiol; 2008 Nov; 103(6):598-610. PubMed ID: 18846354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]